Journal info
|
||
Select Journal
Journals
Bratislava Medical Journal Endocrine Regulations General Physiology and Biophysics Neoplasma 2024 Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Neoplasma Vol.67, No.1, p.119–128, 2020 |
||
Title: Decreased expression of SorCS1 in colorectal cancer: An independent predictor of poor prognosis | ||
Author: P. Z. Huang, S. Y. Peng, H. C. Yu, L. Huang, Q. Yao, X. L. Wang, S. Y. Tan, J. M. Zhou, P. N. Wang, A. P. Huang, L. L. Bai, Y. X. Luo, M. J. Huang | ||
Abstract: Previously, we identified that sortilin related VPS10 domain containing receptor 1 (SorCS1) was hypermethylated in colorectal cancer (CRC) tissues. Here, we aimed to investigate the association between CRC and SorCS1. DNA methylation was determined by methylation-specific polymerase chain reaction (MSP) or quantitative real-time methylation analysis (MethyLight). Colorectal cancer tissue specimens from 239 patients that had undergone surgical treatment were evaluated using immunohistochemistry (IHC) analysis for the expression of SorCS1 and correlated with clinicopathological variables and prognosis. We found that SorCS1 was hypermethylated in CRC cell lines and 67.5% (27/40) CRC tumor tissues. The loss of SorCS1 mRNA (p may be a promising prognostic factor in CRC patients. |
||
Keywords: SorCS1, colorectal cancer, predictor, methylation | ||
Published online: 29-Jan-2020 | ||
Year: 2020, Volume: 67, Issue: 1 | Page From: 119, Page To: 128 | |
doi:10.4149/neo_2019_190221N146 |
||
|
download file |
|